Table Of Content

Contents of Volume 132 - 1997 Aberman J — Trevitt JT amine in Nijmegen high and low respond- studying food or drug seeking in rhesus Adler L — Caligiuri MP ers to novelty: a dose-effect analysis of spa monkeys 209 Agmo A — Belzung C tio-temporal programming of behaviour Foltin RW — Haney M Ahmed SH, Koob GF Cocaine- but not food 181 Foltin RW — Ward AS seeking behavior is reinstated by stress after ‘ools AR > Gingras MA Fournié-Zaluski MC — Smadja C extinction 289 ‘oric P > Smadja C Fowler BM — Hernandez LI Anderson R, HigginsGA : Absence of central ‘ossu G > Martellotta MC Fowler SC — StanfordJ A cholinergic deficits in ApoE knockout mice ‘otter PA > Kumari V Frankel W —C rawley JN 135 ‘owen PJ — Sargent P Fratta W — Martellotta MC Arnone M, Maruani J, Chaperon F, Thiébot ‘rabbe JC — Crawley JN Frieboes R-M, Murck H, Wiedemann K, M-H, Poncelet M, Soubrié P, Le Fur G: ‘rawley JN, Belknap JK, Collins A, Crabbe Holsboer F, Steiger A: Open clinical trial Selective inhibition of sucrose and ethanol JC, Frankel W, Henderson N, Hitzemann on the sigma ligand panamesine in patients intake by SR 141716, an antagonist of cen- RJ, Maxson SC, Miner LL, Silva AJ, with schizophrenia 82 tral cannabinoid (CB1) receptors 104 Wehner JM, Wynshaw-Boris A, Paylor R: Arnsten AFT — Dyck CH van Behavioral phenotypes of inbred mouse Geyer MA — Dulawa SC strains: implications and recommendations Gingras MA, Cools AR: Different behavioral Bair KD — Hernandez LL for molecular studies 107 effects of daily or intermittent dexamphet Balster RL — Wiley JL Crawley JN — Paylor R amine administration in Nijmegen high and Barden N — Rochford J low responders 188 Beauchamp V — Heyser CJ Davidson MC — Witte EA Gingras MA —C ools AR Beaulieu S + Rochford J Dawson GR — Collinson N Glowa JR — Rochford J Bech B — Ulrichsen J Depoortere R, Perrault G, Sanger DJ: Potenti- Gold LH — Heyser CJ Belknap JK — Crawley JN ation of prepulse inhibition of the startle re- Gray JA > Kumari V Belzung C, Agmo A: Naloxone blocks anxio flex in rats: pharmacological evaluation of Greenblatt DJ — Moltke LL von lytic-like effects of benzodiazepines in the procedure as a model for detecting anti Guimaraes FS — Matheus MG Swiss but not in Balb/c mice 195 psychotic activity 366 Benkert O — Roschke J Diemer NH — Ulrichsen J Haney M, Comer SD, Fischman MW, Foltin Bergman J — Carey GJ Duan SX — Moltke LL von RW: Alprazolam increases food intake in Bjorklund M — Jakala P Dulawa SC, Hen R, Scearce-Levie K, Geyer humans 311 Boyer P — Moller HJ MA: Serotonin,, receptor modulation of Haney M — Ward AS Britton KT, Southerland S, Van Uden I startle reactivity, habituation, and prepulse Harmatz JS — Moltke LL von Kirby D, Rivier J, Koob G: Anxiolytic inhibition in wild-type and serotonin, , Harmer CJ, Hitchcott PK, Morutto SL, Phil activity of NPY receptor agonists in the knockout mice 125 lips GD: Repeated d-amphetamine enhanc conflict test 6 Dyck CH van, Lin CH, Robinson R, es simulated mesoamygdaloid dopamine Byrd LD — Schama KF Cellar J, Smith EO, Nelson JC, Arnsten transmission 247 AFT, Hoffer PB: The acetylcholine releaset Harmer CJ — Hitchcott PK Cabib S, Oliverio A, Ventura R, Lucchese F, linopirdine increases parietal regional cere Haugbegl S — Ulrichsen J Puglisi-Allegra S: Brain dopamine receptor bral blood flow in Alzheimer’s disease Heeren D — Cools AR plasticity: testing a diathesis-stress hypothe 217 Hemmingsen R — Ulrichsen J sis in an animal model 153 Hen R > Dulawa SC ‘aligiuri MP, Lohr JB, Rotrosen J, Adler L, Ebert B — Ulrichsen J Henderson N —C rawley JN Lavori P, Edson R, Tracy K, Veterans Af- Edson R — Caligiuri MP Hengeveld MW — Verkes RJ fairs Cooperative Study #394 Study Group Effects of lorazepam administration on striatal Henricks KK, Miner LL, Marley RJ: Differen- Reliability of an instrumental assessment of dopamine D, receptor binding characteris- tial cocaine sensitivity between two closely tardive dyskinesia: results from VA Cooper tics in man — a positron emission tomogra- related substrains of CS7BL mice 161 ative Study #394 61 phy study — Hietala J Hernandez LL, Watson KL, Fowler BM, Bair ‘arey GJ, Bergman J: Discriminative-stimulus El-Kadi AOS, Sharif SI: The influence of KD, Singha AK: Opioid modulation of at- effects of clozapine in squirrel monkeys: chronic treatment with clonidine, yohim- tention-related responses: peripheral-to comparison with conventional and novel bine and idazoxan on morphine withdrawal central progression and development of mu antipsychotic drugs 261 67 influence as learning occurs 50 ‘arriero D > Trevitt JT Ellenbroek BA — Cools AR Heyser CJ, McDonald JS, Beauchamp V, ‘arroll ME — Rodefer JS Engbersen A — Cools AR Koob GF, Gold LH: The effects of cocaine ‘ellar J > Dyck CH van Engel JA — Zhang J on operant responding for food in several ‘haperon F — Arnone M Evans SM — Foltin RW strains of mice 202 heckley SA — Kumari \ Hietala J, Kuoppamiiki M, Nagren K, Lehi- ‘ollins A — Crawley JN Fattore L — Martellotta MC koinen P, Syvilahti E, Effects of lorazepam ‘ollinson N, Dawson GR: On the elevated Fekkes D > Verkes RJ administration on striatal dopamine D, re plus-maze the anxiolytic-like effects of the Finn M — Trevitt JT ceptor binding characteristics in man — a 5-HT,, agonist, 8-OH-DPAT, but not the Fischman MW — Haney M positron emission tomography study: 361 anxicgenic-like effects of the 5-HT,, partial Fischman MW — Ward AS Higgins GA — Anderson R agonist, buspirone, are blocked by the 5- Fishkin RJ, Winslow JT: Endotoxin-induced Hitchcott PK, Harmer CJ, Phillips GD: En HT,, antagonist, WAY 100635 35 reduction of social investigation by mice: hanced acquisition of discriminative ap ‘omer SD — Haney M interaction with amphetamine and anti-in- proach following intra-amygdala d-amphet- ‘ools AR, Ellenbroek BA, Gingras MA, Eng- flammatory drugs 335 amine 237 bersen A, Heeren D: Differences in vulner- Fleurot O — Moller HJ Hitchcott PK — HarmerC J ability and susceptibility to dexamphet- Foltin RW, Evans SM: A novel protocol for Hitzemann RJ — Crawley JN I\ Hoffer PB > Dyck CH van Nagren K > Hietala J Shader RI » Moltke LL von Holsboer I > Frieboes R-M Nelson IC > DyckC H van Sharif SI > El-Kadi AOS Howell LI > Schama KI Silva AJ —C rawley JN Hughes KM » Wolgin DI Odontiadis J — Sargent P Singha AK — Hernandez LI Oliverio A > Cabib S SmadjaC , Ruiz F, Coric P, Fournié-Zaluski Jackson DM — Zhang J Olsen CH — Ulrichsen J MC, Roques BP. Maldonado R: CCK-B re Jikala P, Puoliviili J, Bjorklund M, Koivisto I O'Neill MF, Parameswaran T: RU24969-in ceptors in the limbic system modulate the Riekkinen PJi Activationo f acetyl! duced behavioural syndrome requires acti antidepressant-like effects induced by en choline receptors and 5-H1 receptors have vation of both SHT,, and 5H1T receptors dogenous enkephalins 227 idditive effects in the suppression of neo 55 Smith EO — Dyck CH van cortical high-voltage spindles in aged rats Soubrié P — Arnone M 270 Parameswaran T >O 'Neill MI Southerland S > Britton KT Johansson (¢ > Zhang J Paylor R, Crawley JN: Inbred strain differ Stanford JA, Fowler SC: Similarities and dif ences in prepulse inhibition of the mouse ferences between the subchronic and with- Kelley AE —Z hang M startle response 169 drawal effects of clozapine and olanzapine Kerkhof Ad JFM — Verkes RJ Paylor R >C rawley JN on forelimb force steadiness 408 Kirby D sritton KT Pearson G — Sargent P Steiger A — Frieboes R-M Kégel P > Roschke J Perrault G — Depoortere R Svensson I > Zhang J Koivisto I aikalaP Phillips GD — Harmer CJ Syvalahti E — Hietala J Koob G — Britton KT Phillips GD — Hitchcott PK Koob GI Ahmed SH Poncelet M — Arnone M rhiébot M-H — Arnone M Koob Gl > Heyser CJ PROD-ASLP Study Group > Moller HJ Tracy K — Caligiuri MP Kumari V, Cotter PA, Checkley SA, Gray JA Puglisi-Allegra S — Cabib S Trevitt JT, Lyons M, Aberman J, Carriero D, Effect of acute subcutaneous nicotine on Puolivali J > Jukala P Finn M, Salamone JD: Effects of clozapine, prepulse inhibition of the acoustic startle thioridazine, risperidone and haloperidol on reflex in healthy male non-smokers Rein W > Moller HJ behavioral tests related to extrapyramidal RO Riekkinen PJr — Jakali P motor function 74 Kuoppamiki M — Hietala J Rivier J — Britton KT Tuyl JP — Verkes RJ Robinson R — Dyck CH van Lavori P > Caligiuri MP Rochford J, Beaulieu S, Rousse 1, Glowa JR, Ulrichsen J, Ebert B, Haugbol S, Bech B, Ol Le Fur G Arnone M Barden N: Behavioral reactivity to aversive sen CH, Diemer NH, Hemmingsen R: Sero- Lehikoinen P — Hietala J stimuli in a transgenic mouse model of im tonin,, receptor autoradiography during al LiH — Wiley JI paired glucocorticoid (type II) receptor cohol-withdrawal kindling 19 Lin CH — Dyck CH van function: effects of diazepam and FG-7142 l ipsk i BK >»S ams-Dodd I 145 Van der Mast RC > Verkes RJ Lohr JB — Caligiuri MP Rodefer JS, Carroll MI A comparison of pro Van Kempen GMJ —> Verkes RJ Lucchese | > CabibS gressive ratio schedules versus behavioral Van Uden E = Britton KT Lyons M > Trevitt JT economic measures: effect of an alternative Ventura R > Cabib S reinforcer on the reinforcing efficacy of Verkes RJ, Fekkes D, Zwinderman AH Maldonado R — Smadja ¢ phencyclidine 95 Hengeveld MW, Van der Mast RC, Tuy! JP. Mann K — Roschke J Roques BP > Smadja C Kerkhof Ad JFM, Van Kempen GMJ: Plate Marley RJ — Henricks KK Réschke J, K6gel P. Schlésser R, Wagner P. let serotonin and [*H]paroxetine binding Marrocco RT — Witte EA Mann K, Rossbach W, Benkert O Analysis correlate with recurrence of suicidal behav Martellotta MC, Fattore L, Cossu G, Fratta W of sleep EEG microstructure in subchronic ior 89 Rewarding properties of gamma-hydroxy paroxetine treatment of healthy subjects Veterans Affairs Cooperative Study #394 Stu butyric acid: an evaluation through place 44 dy Group — Caligiuri MP preference paradigm | Rossbach W > Rdschke J Maruani J — Arnone M Rotrosen J > Caligiuri MP Wagner P — Roschke J Matheus MG, Guimaraes FS: Antagonism of Rousse | > Rochford J Ward AS, Haney M, Fischman MW, Foltin non-NMDA receptors in the dorsal peri Ruiz F > Smadja C RW: Binge cocaine self-administration in aqueductal grey induces anxiolytic effect in humans: intravenous cocaine 375 the elevated plus maze 14 Salamone JD — Trevitt JT Watson KL — Hernandez LI Maxson SC — Crawley JN Sams-Dodd F, Lipska BK, Weinberger DR Wehner JM —C rawley JN McDonald JS — Heyser CJ Neonatal lesions of the rat ventral hippo Weinberger DR — Sams-Dodd | Miner LL —>C rawley JN campus result in hyperlocomotion and defi Wiedemann K — Frieboes R-M Miner LL — Henricks KK cits in social behaviour in adulthood 303 Wiley JL, Li H, Balster RL: Discriminative Moller HJ, Boyer P, Fleurot O, Rein W, Sanger DJ >| Jepoortere R stimulus effects of site-selective N-methy]l- PROD-ASLP Study Group Improvement Sargent P, Williamson DJ, Pearson G, Odon b-aspartate antagonists in NPC 17742-trai- of acute exacerbations of schizophrenia tiadis J, Cowen PJ: Effect of paroxetine and ned rats and squirrel monkeys 382 with amisulpride: a comparison with halo- nefazodone on 5-HT receptor sensitivity Williamson DJ — Sargent P peridol 396 296 Winslow JT — Fishkin RJ Moltke LL von, Greenblatt DJ, Duan SX, Scearce-Levie K — Dulawa SC Witte EA, Davidson MC, Marrocco RT Schmider J, Wright CE, Harmatz JS, Schama KF, Howell LL, Byrd LD: Serotoner Effects of altering brain cholinergic activity Shader RI: Human cytochromes mediating gic modulation of the discriminative-stimu- on covert orienting of attention: com- N-demethylation of fluoxetine in vitro lus effects of cocaine in squirrel monkeys parison of monkey and human performance tel 402 324 Morutto SI > Harmer CJ Schlosser R + Réschke J Witte EA, Marrocco RT Alteration of brain Murck H > Frieboes R M Schmider J >» Moltke LL von noradrenergic activity in rhesus monkeys affects the alerting component of covert Wynshaw-Boris A —C rawley JN injected into the nucleus accumbens en orienting 315 hance sucrose drinking in rats 350 Wolgin DL, Hughes KM: Role of behavioral Zhang J, Engel JA, Jackson DM, Johansson Zwinderman AH — Verkes RJ and pharmacological variables in the loss C, Svensson L: (—)Alprenolol potentiates of tolerance to amphetamine hypophagia the disrupting effects of dizocilpine on sen- Indexed in Current Contents, 342 sorimotor function in the rat 281 Psvye hologi« al Abstracts, Wright CE > Moltke LL von Zhang M, Kelley AE: Opiate agonists micro Psyc INI O, Index Medicus and in EMBASI Subject index of Volume 132 - 1997 Acetylcholine 74 ‘annabinoid receptor 104 Food intake 209, 311 Acoustic startle 107, 169 ‘arbohydrate 311 Food reward 350 Acoustic startle reflex 389 ‘ardiovascular effects 375 Footshock 289 Acoustic startle response 281 “audate nucleus 227 Force 408 Aggression 107 ‘CK-B receptors 227 Forelimb 408 Alcohol 107 ‘entral amygdala 227 Free exploratory test 195 Alcohol withdrawal 19 ‘hlorpromazine 26] GABAa receptor 6 Alerting 315, 324 ‘holinergic system 135 Gamma-hydroxybutyric acid | Alprazolam 311 lonidine 67, 31: Genetic 16] Alternative reinforcer lothiapine 261 Genetic liability 132 Alzheimer’s disease lozapine 261, 366, 408 Genetics 107, 202 Amisulpride 366, 396 "NS 35 Gepirone 296 Amoxapine 26] ‘ocaine 27, 107, 161, 202, 209, 289, 37 5 Glucocorticoid receptor 145 Amphetamine 181, 342 ‘onditioned place preference 1, 209 Glutamate 14 Amygdala 237, 247 ‘onditioned reward 237 Glycine site 382 A\npirtoline 255 ‘onflict test 6 Guanfacine 315 Antagonist 74 ‘ontext 289 Habituation 125 ‘ — Anterior nucleus accumbens 22 orticosteroid 335 Haloperidol 107. 261. 366. 396 Antidepressant-like effects 227 RRAARAARRAARRAAA ‘RARRRAAo v eRrt orienting 324 Healthy subjects 44 Antioxidant 61 CTOP 50 Heart rate 50 Antipsychotic 408 Cyclooxygenase inhibitor Hippocampus 303 Antipsychotics 366 Cytochromes 402 5-HT 8&9 Anxiety 6 D2 receptors 132 5-HT 35 Anxiogenic 35 DAMGO 350 5-HT receptor Anxiolytic 35 d-Amphetamine 327 SHT receptors Anxiolytic effect 14 Desensitization 188 SHT B receptors \polipoproteinE 135 Dexamphetamine 188 5-HT receptors \pomorphine 366 Diazepam 107, 145 Human 311, 375, 402 Atropine 324 Dopamine 74, 237, 247, 281, 361, 366 Hyperactivity 303 Attention 50, 315, 324 Dorsal periaqueductal grey 14 Hyperphagia 311 Atypical 408 DPEN 350 Idazoxan 67 Atypical antipsychotic 261, 396 Drug discrimination 27, 261 Inbred mice 169 Atypical antipsychotic drug 82 Drug relapse 289 Inbred strains 107 Atypical neuroleptic 74 Drug self-administration 95, 289 Individual differences 181 Autoradiography 19 Drug withdrawal 342 Individual susceptibility 188 Autoreceptor 132 Drug-reinforced behavior 95 Instrumental learning 342 Aversive stimuli 145 Drug-seeking 289 Instrumentation 6] Balb,c mice 195 Dynorphin 350 Internal state 289 Behavior 107 E2020 (donepezil) 135 Interrater reliability 61 Behavioral economics 95 Elevated plus-maze_ 14, 35 Intravenous 375 Behavioural genetics 132 Embryonic stem cell lines 107 JL5 261 Benzodiazepine 36! Enkephalin degrading enzymes 227 JIL& 261 Benzodiazepines 195 Ethanol consumption 104 JL 18 261 Bezodiazepines 31] Excitatory amino acids 14 Ketanserin 7 Binding sites 89 Extinction 289 Kindling 19, 16] Binge 375 Extrapyramidal operant 74 Knockouts 107 Borderline personality disorder 89 Extrapyramidal symptoms 82 Learning 107 Break point 95 Fat 311 Light, dark anxiety test 195 Breeding 107 FG-7142 Linopirdine 217 Buspirone 35 Flavone Locomotion 107 BXRID stra ins 132 Fluoxetine 27, 402 Locomotor activity 18] CS7BL mouse 161 Fluperlapine 261 Lorazepam 361 Vi Loxapine 26] Pavlovian learning 50 Sensitization 161, 188 Macronutrient 311 PD-134,308 227 Sensorimotor gating 125, 169 Memory 107 Peripheral opioids 50 Seroquel 261 Mice 104, 125, 202 Perlapine 261 Serotonin 27, 74, 89, 281 Microdialysis 24 Phencyclidine 95 Serotonin receptors 19 Microsomes 402 (+)-PHNO 261 Serotonin), receptor 125 Microstructure 44 Platelets 89 Sertindole 261 Monkey 315, 324 Polyaminseit e 382 Sickness behavior Monoamine oxidase activity Positive symptoms 303 Sigma ligand 82 Morphine 67, 350 Positron emission tomography 361 Sleep EEG 44 Motor 14 Prazosin 366 Social behaviour 303 Mouse 10 Prepulse inhibition 107, 125 169, 281 366 SPECT 217 Mu receptors 50 389 Spectral power analysis 44 Multi-center study 61 Productive symptoms 396 Squirrel monkey 27 Muscarinic acetylcholine recep Progressive ratio 95 Squirrel monkeys 261 Naloxone 50, 67 Protein 311 SR 141716 104 N-Demethylation 402 Psychomotor 1I6l1 Startle 125 Nefazodone 296 Psychopathology Startle reflex 366 Negative symptoms 303 Psychosis 361 Stereotypy 342 Neocortical high-voltage spindles Quaternary naloxone 50 Stimulus-reward learning Neonate 404 Quipazine 27, 408 Strain differences 195 Neuroleptics 408 Rabbits 50 Stress 132, 289 Neuropeptide Y 6 Raclopride 361, 366 Subchronic 408 Nicotine 107, 324 Rat 1, 281, 303, 366 Subcutaneous nicotine 389 Nicotinic acetylcholine receptors Rats 35, 104, 188 Subjective effects 375 NMDA antagonists 382 RB 101 227 Sucrose intake 104, 350 Non-NMDA receptor 14 Reaction times 315, 324 Suicide attempts 89 Non-smoketr 3RO Reinforcing efficacy 95 Swiss mice 195 Novelty 18] Reinstatement 289 Tactile startle 169 NPC | }° 3k? 382 Remoxipride 261, 366 Tardive dyskinesia 61] Nucleu iccumbens Residential laboratory 311 [""]Tc-ECD 217 Null mutatior 10 Retentiono f tolerance 342 Chalamocortical oscillations 8-OH-DPAT 35, 125 Rhesus monkey 209 Thioridazine 26] Olanzapine 261, 408 Rhesus monkeys 95 Tolerance 161, 342, 408 pen field activit 10 Risperidone 261, 366 [Transgenic 107 Operant behavior 202 Ritanserin _— Transgenic mice 135 Opiates 10 Rohitukine 335 Transgenic mouse 145 Opioids 195, 350 RU24969 125, 255 Tremor 408 Oral 209 Saccharin 95 Irihexyphenidyl 408 Orienting response Schizophrenia 82 12255, .22 81, 303 500, 396 US0488H 350 Palatability 350 Secondary negative symptoms 3906 Ventral tegmental area 132 Panamesine 82 Seizure 161 WAY 100635 35 Parental behaviors 10 Seizures 19 Withdrawal 67 Paroxetine 44, 296 Self-administration 209, 375 Yohimbine 67 H Paroxetine 8&9 Sensitisation 247 |